Bioavailability of antiinflammatory drugs;Biodisponibilite des anti-inflammatoires

Journal Francais d'Ophtalmologie

Volumn 23, Issue 5, 2000, Pages 514-517

  Cochereau, I ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Antimetabolites; Bioavailability; Corticosteroids; Non steroidal antiinflammatory drugs

Indexed keywords

ANTIINFLAMMATORY AGENT; DAUNORUBICIN; EYE DROPS; FLUOROURACIL; METHYLPREDNISOLONE SODIUM SUCCINATE; MITOMYCIN C; PREDNISOLONE 3 SULFOBENZOATE; PREDNISONE ACETATE; STEROID; DIAGNOSTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; EYE INFLAMMATION; HUMAN; IMMUNOMODULATION; ANIMAL; BIOAVAILABILITY; EYE; EYE DISEASE; METABOLISM; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; EYE; EYE DISEASES; HUMANS;

EID: 0034096346     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Leibowitz HM, Kupferman A. Kinetics of topically administered prednisolone acetate. Optimal concentration for treatment of inflammatory keratitis. Arch Ophthalmol 1976;94:1387-9.
2. Leibowitz HM, Berrospi AR, Kupferman A, Restropo GV, Galvis V, Alvarez JA. Penetration of topically administered prednisolone acetate into the human aqueous humor. Am J Ophthalmol 1977;83:402-6.
3. Leibowitz HM, Kupferman A, Stewart RH, Kimbrough RL. Evaluation of dexamethasone acetate as a topical ophthalmic formulation. Am J Ophthalmol 1978;86:418-23.
4. Janes RG, Stiles JF. The penetration of cortisol into normal and pathological rabbit eyes. Am J Ophthalmol 1963;56: 84-90.
5. McGhee CN, Noble MJ, Watson DG, Dutton GN, Fern AI, Migdley JM. Penetration of topically applied prednisolone sodium phosphate into human aqueous humour. Eye 1989;3:463-67.
6. McGhee CN, Watson DG, Midgley JM, Noble MJ, Dutton GN, Fern AI. Penetration of synthetic corticosteroids into human aqueous humour. Eye 1990;4: 526-30.
7. Leibowitz HM, Kupferman A. Optimal frequency of topical prednisolone administration. Arch Ophthalmology 1979; 97:2154-6.
8. Schoenwald RD, Boltralik JJ. A bioavailability comparison in rabbits of two steroids formulated as high-viscosity gels and reference aqueous preparations. Invest Ophthalmol Vis Sci 1979;18:61-6.
9. Johansen S, Rask-Pedersen E, Prause JU. A bioavailability comparison in rabbits after a single topical ocular application of prednisolone acetate formulated as a high-viscosity gel and as an aqueous suspension. Acta Ophthalmol Scand 1996;74:253-8.
10. Johansen S, Rask-Pedersen E, Prause JU. An ocular bioavailability comparison in rabbits of prednisolone acetate after repeated topical applications formulated as a high-viscosity gel and as an aqueous suspension. Acta Ophthalmol Scand 1996;74:259-64.
11. Cox WU. Topically applied steroids in corneal disases II. The role of drug vehicle in stromal absorbtion of dexamethasone. Arch Ophthalmol 1972;88:549-52.
12. Tsuji A, Tamai I, Sasaki K. Intraocular penetration kinetics of prednisolone after subconjunctival injection in rabbits. Ophthalmic Res 1988;20:31-43.
13. Bodker FS, Ticho BH, Feist RM, Lam TT. Intraocular dexamethasone penetration via subconjunctival or retrobulbar injections in rabbits. Ophthalmic Surgery 1993;24:453-57.
14. Weijtens O, Schoemaker RC, Cohen AF, Van Meurs JC. Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection. Am J Ophtalmol 1997;123:358-63.
15. Weijtens O, Schoemaker RC, Cohen AF, Romijn F, Lentjes E, Van Rooij J, et al. Dexamethasone concentration in vitreous and serum after oral administration. Am J Ophtalmol 1998;125:673-79.
16. Schinder RH, Chandler D, Tresher R, Machemer R. The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol 1982;93:415-7.
17. Scholes GN, O'Biren WJ, Abrams GW, Kubicek MF. Clearance of triamcinolone from vitreous. Arch Ophthalmol 1985; 103:1567-9.
18. Anyedi LB, Pearson PA, Ashton P, Jaffe GJ. An intravitreal device providing sustained release of cyclosporine and dexamethasone. Curr Eye Res 1996;15:549-57.
19. Bucolo C, Mangiafico S, Spadaro A. Methylprednisolone delivery by Hyalobend corneal shields and its effects on rabbit ocular inflammation. J ocul Pharmacol Ther 1996;12:141-9.
20. Komatsu A, Ohashi K, Oba H, Kakehashi T, Mizushima Y, Shirasawa E, et al. Application of lipid microsphere drug delivery system to steroidal ophthalmic preparation. Jpn J Ophthalmol 1988;32: 41-3.
21. Al-Muhammed J, Ozer AY, Ercan MT, Hincal AA. In-vivo studies on dexamethasone sodium phosphate liposomes. J Microencapsul 1996;13:293-306.
22. Lam TT, Edward DP, Zhu XA, Tso MO. Transscleral iontophoresis of dexamethasone. Arch Ophthalmol 1989;107:1368-71.
23. Waga J, Ehinger B. Intravitreal concentrations of some drugs administratered with microdialysis. Acta Ophthalmol Scand 1997;75:36-40.
24. Rabiah PK, Fiscella RG, Tessler HH. Intraocular penetration of periocular ketorolac and efficacy in experimental uveitis. Invest Ophthalmology Vis Sci, 1996; 37:613-8.
25. Ellis PP, Pfoff DS, Bloedow DC, Riegel M. Intraocular diclofenac and flurbiprofen concentrations in human aqueous humor following topical application. J Ocul harmacol 1994;10:677-82.
26. Gimbel H, Van Westenbgugge J, Cheetham JK, De Gryse R, Garcia CG. Intraocular availability and pupillary effect of flurbiprofen and indomethacin during cataract surgery. J Cataract Refract Surg, 1996;22:474-9.
27. Hessemer V, Schmitt K, Jacobi A. Antiinflammatory effects and aqueous humor concentration of various monsteroidal anti-inflammatory drugs in extracapsular cataract surgery. Klin Monatsbl Augenheilkb, 1996;208:161-6.
28. Kawase K, Matsushita H, Yamamoto T, Kitazawa Y. Mitomycin concentration in rabbit and human ocular tissues after topical administration. Ophthalmology 1992;99:203-7.
29. Fantes FE, Heuer DK, Parrish RK 2d, Sossi N, Gresseil MG. Topical fluorouracil. Pharmacokinetics in normal rabbit eyes. Arch Ophthalmol 1985;103:953-5.
30. Rabowsky JH, Dukes AJ, Lee DA, Leong KW. The use of bioerodible polymers and daunorubicin in glaucoma filtration surgery. Ophthalmology 1996;103:800-7.
31. Tetz MR, Ries MW, Lucas C, Stricker H, Volcker HE. Inhibition of posterior capsule opacification by an intraocular-lensbound sustained drug delivery system: an experimental animal study and literature review. J Cataract Refract Surg 1996;22:1070-8.
32. Wiedemann P, Hilgers RD, Bauer P, Heimann K. Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol 1998;126:550-9.